Skip to main content
. 2021 Mar 10;25(8):4088–4098. doi: 10.1111/jcmm.16378

FIGURE 5.

FIGURE 5

Subgroup analysis of the ALPS for (A) age > 65 y; (B) age < 65 y; (C) M0;(D) ER positive;(E) PR positive;(F) HER2 positive;(G) ER negative;(H) PR negative;(I) HER2 negative;(J) stage I‐II;(K) NO;(L) T1‐2;(M) stage III‐IV;(N) N1‐3;(O) T3‐4